Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | 0 to 19 | 20 to 29 | 30 to 39 | 40 to 49 | 50 to 59 | 60 and over |
|---|---|---|---|---|---|---|
| British Columbia | 4% | 14% | 25% | 19% | 19% | 19% |
| Alberta | 5% | 18% | 23% | 16% | 14% | 24% |
| Saskatchewan | 7% | 15% | 22% | 19% | 16% | 21% |
| Manitoba | - | 18% | 22% | 18% | - | 25% |
| Ontario | 4% | 12% | 20% | 16% | 17% | 31% |
| New Brunswick | - | 17% | - | - | 17% | 56% |
| Nova Scotia | - | - | - | 20% | 17% | 33% |
| Prince Edward Island | 0% | 0% | - | - | - | 56% |
| Newfoundland and Labrador | 0% | - | - | - | 38% | 38% |
| Canada | 4% | 14% | 22% | 17% | 17% | 25% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
June 2023
More information
Region
Canada
Survey time period
2022
Supplementary notes
Figures missing in the provinces shown mean the data may be suppressed due to low numbers of cases in order to comply with privacy and confidentiality rules. Adapted from Statistics Canada, Opioid and Stimulant Poisoning Hospitalizations, page 48, 2022. This does not constitute an endorsement by Statistics Canada of this product.
Citation formats
